ITEOS THERAPEUTICS INC (ITOS) Stock Ownership
NASDAQ:ITOS • US46565G1040
Current stock price
10.15 USD
+0.02 (+0.2%)
At close:
10.17 USD
+0.02 (+0.2%)
After Hours:
ITOS Ownership information
| Shares Outstanding | 44.21M |
| Float | 42.98M |
| Float Short Interest Percentage | N/A |
| Owners (insider) | 1.18% |
| Owners (institutional) | 104.81% |
| Owners (insider) change | 0% |
| Owners (institutional) change | 0% |
| Date | Name | Type | Shares | Price | Amount |
|---|---|---|---|---|---|
| Aug 29, 2025 | Call Matthew | Other Disposition | 161898 | $ 0.00 | |
| Aug 29, 2025 | Detheux Michel | Other Disposition | 247930 | $ 0.00 | |
| Aug 29, 2025 | Feltquate David | Other Disposition | 47000 | $ 0.00 | |
| Aug 29, 2025 | Gall Matthew | Other Disposition | 89429 | $ 0.00 | |
| Aug 29, 2025 | McGrath Yvonne | Other Disposition | 46300 | $ 0.00 | |
| Jun 9, 2025 | Detheux Michel | Option Excercise | 216592 | 4.30 | $ 931,345.60 |
| Jun 9, 2025 | Detheux Michel | Open Market Sale | 104565 | 10.02 | $ 1,048,264.12 |
| Jun 4, 2025 | Detheux Michel | Open Market Sale | 156847 | 10.15 | $ 1,592,519.82 |
| Jun 4, 2025 | Hallal David | Option Excercise | 114682 | 4.30 | $ 493,132.60 |
| Jun 4, 2025 | Hallal David | Open Market Sale | 114682 | 10.15 | $ 1,164,404.66 |
| Jun 4, 2025 | Detheux Michel | Option Excercise | 156847 | 4.30 | $ 674,442.10 |
| May 14, 2025 | EcoR1 Capital, LLC | Open Market Purchase | 4958978 | 7.80 | $ 38,685,561.58 |
| May 13, 2025 | Van Hauwermeiren Timothy | Option Excercise | 22346 | 4.30 | $ 96,087.80 |
| May 13, 2025 | GADICKE ANSBERT | Open Market Sale | 1031931 | 8.06 | $ 8,317,363.86 |
| May 13, 2025 | MPM Oncology Impact Management LP | Open Market Sale | 1031931 | 8.06 | $ 8,317,363.86 |
| May 13, 2025 | Oncology Impact Fund (Cayman) Management L.P. | Open Market Sale | 1031931 | 8.06 | $ 8,317,363.86 |
| May 13, 2025 | UBS Oncology Impact Fund L.P. | Open Market Sale | 1031931 | 8.06 | $ 8,317,363.86 |
| May 13, 2025 | MPM BioVentures 2014, L.P. | Open Market Sale | 630191 | 8.06 | $ 5,079,339.46 |
| May 13, 2025 | MPM BioVentures 2014 (B), L.P. | Open Market Sale | 630191 | 8.06 | $ 5,079,339.46 |
| May 13, 2025 | MPM Asset Management Investors BV2014 LLC | Open Market Sale | 630191 | 8.06 | $ 5,079,339.46 |
| May 13, 2025 | MPM BioVentures 2014 GP LLC | Open Market Sale | 630191 | 8.06 | $ 5,079,339.46 |
| May 13, 2025 | MPM BioVentures 2014 LLC | Open Market Sale | 630191 | 8.06 | $ 5,079,339.46 |
| May 13, 2025 | MPM BIOVENTURES 2018 (B), L.P. | Open Market Sale | 630191 | 8.06 | $ 5,079,339.46 |
| May 13, 2025 | MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | Open Market Sale | 630191 | 8.06 | $ 5,079,339.46 |
| May 13, 2025 | EVNIN LUKE | Open Market Sale | 630191 | 8.06 | $ 5,079,339.46 |
| May 13, 2025 | Foley Todd | Open Market Sale | 630191 | 8.06 | $ 5,079,339.46 |
| May 13, 2025 | MPM BIOVENTURES 2018, L.P. | Open Market Sale | 630191 | 8.06 | $ 5,079,339.46 |
| May 13, 2025 | MPM BioVentures 2018 LLC | Open Market Sale | 630191 | 8.06 | $ 5,079,339.46 |
| May 13, 2025 | MPM BioVentures 2018 GP LLC | Open Market Sale | 630191 | 8.06 | $ 5,079,339.46 |